Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
French drugmaker Sanofi on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation ...
Sanofi partners with OpenAI: here’s how it will mitigate AI related risks
Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development.
Briefly on MSN13 天
Sanofi allies with OpenAI, Formation Bio for AI use in drug development
French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech ...
Reuters12 天
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
, opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial ...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug ...
雅虎財經13 天
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Paris, New York, N.Y., and San Francisco, CA, May 21, 2024. Sanofi, Formation Bio and OpenAI are collaborating to build AI-powered software to accelerate drug development and bring new medicines to ...
Investing13 天
Sanofi partners with OpenAI, Formation Bio on AI-driven drug development
(Reuters) - French drugmaker Sanofi (NASDAQ:SNY) on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects ...